55 completed, 9 terminated, 5 active not recruiting, 5 unknown. 20 Phase 3, 18 Not applicable, 11 Phase 2, 5 Phase 4, 2 Phase 1.
Follow Carelon Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT Trametinib - HCM, Noonan Syndrome and Other Rasopathy | Phase 3 | Not yet recruiting | Carelon Research | 25 | 2027-08-01 | 2026-09-14 |
| Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD) HeartGPS - Congenital Heart Disease (CHD) | Not applicable | Recruiting | Carelon Research | 210 | 2026-07-22 | 2026-09-10 |
| BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD) - Congenital Heart Disease (CHD) | Not applicable | Recruiting | Carelon Research | 266 | 2026-07-22 | 2026-09-10 |
| A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study Telemedicine-based resiliency-building intervention - Patient-Reported Outcome Measures (PROMs), Pragmatic Trial | Not applicable | Recruiting | Carelon Research | 390 | 2026-04-20 | 2026-10-16 |
| ACHIEVE Pilot Statins for Vascular Protection Pharmacist call - ASCVD | Completed | Duke University | 225 | 2025-05-19 | 2026-07-01 | |
| Pumps for Kids, Infants and Neonates (PumpKIN): The Jarvik 2015 Pivotal Trial Jarvik 2015 LVAD - Heart Failure With Reduced Ejection Fraction, Pediatric HD, Stage IV | Not applicable | Not yet recruiting | Stanford University | 22 | 2024-08-01 | 2024-04-04 |
| A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2 Educational Materials - Alzheimer Disease | Not applicable | Completed | University of Massachusetts, Worcester | 11375 | 2024-07-01 | 2026-02-12 |
| Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant) Daridorexant, Non-orexin receptor antagonist insomnia medication, No insomnia medication - Insomnia Disorder | Active not recruiting | Idorsia Pharmaceuticals Ltd. | 2095 | 2023-11-30 | 2025-08-19 | |
| A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old. Cardiac Imaging - Myocarditis | Phase 4 | Active not recruiting | Pfizer | 319 | 2022-11-21 | 2026-05-07 |
| Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) Ductal Arterial Stent, Systemic-to-Pulmonary Artery Shunt - Congenital Heart Disease in Children | Not applicable | Active not recruiting | Carelon Research | 300 | 2022-06-02 | 2026-01-07 |
| Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS) Stanford Binet Intelligence Scales, Fifth Edition, Vineland Adaptive Behavior Scales Third Edition, Peabody Picture Vocabulary Test, Fifth Edition - Down Syndrome, Congenital Heart Disease | Completed | Carelon Research | 273 | 2022-05-01 | 2024-01-11 | |
| Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women Fourth Trimester Mobile Tool - Pregnancy Related, Postpartum Sadness | Not applicable | Completed | Carelon Research | 87 | 2021-05-17 | 2023-02-08 |
| Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT passive range of motion exercise therapy - Congenital Heart Disease | Phase 3 | Unknown | Carelon Research | 144 | 2021-02-23 | 2024-07-03 |
| Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Multisystem Inflammatory Syndrome in Children (MIS-C) | Active not recruiting | Carelon Research | 1200 | 2020-09-30 | 2026-03-27 | |
| COVID-19 Citizen Science Expansion Project Covid19 | Completed | University of California, San Francisco | 52351 | 2020-03-18 | 2026-07-08 | |
| Use of Oxandrolone to Promote Growth in Infants With HLHS Oxandrolone - Hypoplastic Left Heart, Congenital Heart Disease | Phase 1 / Phase 2 | Terminated | Carelon Research | 34 | 2019-12-20 | 2024-05-23 |
| Pumps for Kids, Infants, and Neonates Surgical placement of the Jarvik 2015 VAD, Surgical Placement of Jarvik 2015 VAD - Pediatric Heart Failure | Early Phase 1 | Unknown | Carelon Research | 7 | 2018-10-22 | 2023-09-21 |
| Dyslipidemia of Obesity Intervention in Teens Pitavastatin, Placebo - Dyslipidemia, Obesity | Phase 3 | Completed | Carelon Research | 122 | 2018-05-01 | 2024-07-05 |
| Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy), LABA (Long-Acting Beta Agonist) (Triple therapy) - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | Boehringer Ingelheim | 714 | 2017-09-20 | 2022-06-14 |
| The Impact of Diabetes on REvascularization Platelet function testing, Vascular ultrasonography - Peripheral Arterial Disease, Diabetes Mellitus | Completed | Vanderbilt University Medical Center | 215 | 2017-08-01 | 2024-07-08 |
Showing 20 of 80. Sign in to see all of them.
Heart Defects, Congenital (10) · Thalassemia (8) · Cardiovascular Diseases (5) · Heart Diseases (5) · Heart Failure (5) · Urinary Incontinence (5) · Hypertension, Pulmonary (4) · Urinary Incontinence, Stress (4) · Cardiomyopathy, Dilated (3) · Cardiomyopathy, Hypertrophic (3) · Thrombocytopenia (3) · beta-Thalassemia (3) · Anemia, Sickle Cell (2) · COVID-19 (2) · Cognition Disorders (2)
Decitabine (2) · Deferiprone (2) · Deferoxamine (2) · Rituximab (2) · Sildenafil Citrate (2) · Standard of Care (2) · Tadalafil (2) · Adrenal Cortex Hormones (1) · Angioplasty, Balloon, Coronary (1) · Arginine (1) · Atenolol (1) · Blalock-Taussig Procedure (1) · Blood Transfusion (1) · Cognitive Training (1) · Coronary Artery Bypass (1)
United States (69) · Canada (23) · United Kingdom (3) · Finland (2) · India (2) · Italy (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Georgia (1) · Germany (1) · Japan (1) · Netherlands (1) · New Zealand (1)
Ellis Neufeld, MD (6) · Cindy Leissinger, MD (5) · James Bussel, MD (5) · James George, MD (5) · Cassandra Josephson, MD (4) · David Kuter, MD (4) · Janet Kwiatkowski, MD (4) · Jeffrey McCullough, MD (4) · Joseph Kiss, MD (4) · Keith McCrae, MD (4) · Nancy Olivieri, MD (4) · Nigel Key, MD (4) · Susan F Assmann, PhD (4) · Susan F. Assmann, PhD (4) · Ann Zimrin, MD (3)
PMID 20093904, PMID 25800900, PMID 36073629, PMID 12425704, PMID 16622139, PMID 16757723, PMID 17179457, PMID 17301297, PMID 17308942, PMID 17545265, PMID 18248343, PMID 19038400, PMID 19183825, PMID 19329464, PMID 19625327, PMID 19635587, PMID 19850207, PMID 20018326, PMID 20127832, PMID 20164484, PMID 20479459, PMID 20505177, PMID 20560801, PMID 20561642, PMID 20655807, PMID 20813285, PMID 20826251, PMID 20952014, PMID 21146663, PMID 21168857, PMID 21185506, PMID 21331516, PMID 21397260, PMID 21700776, PMID 21772051, PMID 21775897, PMID 22025077, PMID 22113975, PMID 22231150, PMID 22341290, PMID 22341427, PMID 22456475, PMID 22463614, PMID 22466375, PMID 22496156, PMID 22523314, PMID 22531338, PMID 22538854, PMID 22558076, PMID 22558154
U01HL072268 (9), U01HL065238 (8), U01HL068270 (6), U01HL065232 (2), U01HL065239 (2), U01HL065244 (2), U01HL065260 (2), U01HL068279 (2), U01HL068281 (2), U01HL068285 (2), U01HL068288 (2), U01HL068290 (2), U01HL068292 (2), U01HL072033 (2), U01HL072248 (2)